Drugs / AGN-242071
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03316898 | Sep → Nov 2018 | Alzheimer disease | Allergan | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGN-242071 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03316898 ↗ |